Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD | Market Cap | 371.79M -5.5% |
| Revenue (ttm) | 314.07M +12.3% |
| Net Income | -120.13M |
| EPS | -2.07 |
| Shares Out | 65.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 240,199 |
| Open | 5.63 |
| Previous Close | 5.74 |
| Day's Range | 5.57 - 5.71 |
| 52-Week Range | 3.59 - 8.75 |
| Beta | 1.42 |
| Analysts | Hold |
| Price Target | 5.83 (+3.01%) |
| Earnings Date | Nov 12, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for ACB stock is "Hold." The 12-month stock price target is $5.83, which is an increase of 3.01% from the latest price.
News
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will ...
Curaleaf Holdings, Inc. Responds to Alberta Securities Commission Decision Regarding Aurora Cannabis
Curaleaf Holdings, Inc. issued a statement on October 27, 2026, in response to the Alberta Securities Commission ruling regarding Aurora Cannabis Inc.'s at-the-market program. Boris Jordan, Chairman o...
Curaleaf responds to Alberta Securities Commission’s ruling on ATM program
Curaleaf Holdings (CURLF) issued the following statement in response to the Alberta Securities Commission’s ruling regarding Aurora Cannabis’ (ACB) at-the-market program. “Aurora would like shareholde...
Aurora Cannabis Announces Alberta Securities Commission Dismissal of Curaleaf Application on October 26, 2026
Aurora Cannabis Inc. announced that the Alberta Securities Commission has dismissed an application by Curaleaf Holdings, Inc. to halt Aurora's at-the-market program. The company stated that this decis...
Aurora Cannabis reports favorable Alberta Securities Commission ruling
Aurora Cannabis (ACB) announced that the application made by Curaleaf (CURLF) to halt Aurora’s at-the-market, or ATM, program was dismissed by the Alberta Securities Commission. This positive result s...
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
NASDAQ | TSX: ACB Alberta Securities Commission dismisses Curaleaf's application concerning Aurora's ATM program. Curaleaf's unsuccessful application before the Alberta Securities Commission confirms ...
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Curaleaf TodayCURLFCuraleaf$7.80 +0.17 (+2.26%) As of 02:38 PM Eastern52-Week Range$5.40▼$15.15Price Target$6.00Add to WatchlistCuraleaf Holdings, Inc. OTCMKTS: CURLF is aggressively maneuvering to ab...
M&A News: Canada’s Aurora Cannabis (ACB) Rejects Sweetened Takeover Offer
Canada’s largest marijuana producer, Aurora Cannabis ($ACB), has rejected a sweetened takeover offer from American rival Curaleaf Holding ($CURA).
Curaleaf Criticizes Aurora Board Over Unequal Due Diligence Access
(RTTNews) - Monday, Curaleaf Holdings, Inc. (CURLF.PK) shared its response to Aurora Cannabis Inc.'s Notice of Change to its directors' circular, which recommended that shareholders reject Curaleaf's ...
Curaleaf challenges Aurora’s unilateral rejection of its enhanced proposal
Curaleaf Holdings (CURLF) responded to Aurora Cannabis’ (ACB) Notice of Change to its directors’ circular, dated October 14, 2026, in which Aurora’s Board again recommended that shareholders reject Cu...
Aurora entered confidentiality agreements with multiple parties amid review
Aurora Cannabis (ACB) said that its special committee, with the assistance of its advisors, is actively exploring a range of alternatives that may offer shareholders greater value than Curaleaf’s (CUR...
Aurora Cannabis reconfirms recommendation to reject Curaleaf offer
Aurora Cannabis (ACB) reconfirms that its board, on the unanimous recommendation of a special committee of independent directors, unanimously recommends that shareholders reject the “hostile offer” by...
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
NASDAQ | TSX: ACB Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board. Aurora's Special Committee is actively exploring strategi...
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up.
Aurora Cannabis completes expansion of European EU-GMP manufacturing facility
Aurora Cannabis (ACB) announced the completion of an expansion of its facility in Leuna, Germany. The expansion project incorporates cultivation and post-harvest practices from Aurora’s Canadian opera...
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
NASDAQ | TSX: ACB Multi-million-dollar investment results in increased domestic production capacity in Germany, more than doubling expected annual flower output. Enhanced facility adopts Aurora's prov...
Aurora Cannabis urges no shareholder action regarding revised Curaleaf bid
Aurora Cannabis (ACB) esponded to a press release issued by Curaleaf Holdings (CURLF) regarding the filing of a Notice of Variation and Change to revise its hostile take-over bid for…
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Aurora's Special Committee will commence a thorough and independent review of the revised Hostile Bid and the Board will provide a formal recommendation to shareholders once the review is complete. ...
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry consolidation. Behind the urge to merge is a significant shift in U.S. federal regulatory policy, en...
Curaleaf files notice to increase offer maximum for Aurora Cannabis
Curaleaf (CURLF) said it has filed a Notice of Variation to increase its offer to acquire Aurora Cannabis (ACB). The filing of the Notice of Variation follows Curaleaf’s announcement yesterday…
M&A News: Curaleaf Revives Takeover Offer For Canada’s Aurora Cannabis (ACB)
U.S.-based Curaleaf Holdings ($TSE:CURA) is taking another run at acquiring Canada’s Aurora Cannabis ($ACB).
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
NASDAQ | TSX: ACB Curaleaf has yet to file a Notice of Variation and Change to revise its offer. Once filed, the Special Committee will complete a thorough and comprehensive review prior to issuing a ...
Curaleaf sweetens takeover offer for Edmonton's Aurora Cannabis
Curaleaf Holdings Inc. says it will sweeten its offer to buy rival pot firm Aurora Cannabis Inc. Curaleaf now wants to make an offer valued at $5 US per Aurora share, up from $4 US earlier this summer...
Curaleaf raises offer to acquire Aurora Cannabis to $6.00 from $5.00 per share
Curaleaf Holdings (CURLF) announced that it will file a Notice of Variation and Change to increase its offer to acquire all of the issued and outstanding common shares of Aurora…
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.
Curaleaf presented an unsolicited offer to buy Aurora Cannabis for $4 per share. Aurora rejected the offer, saying it didn't fully value Aurora's business.